E.E. Geduld’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

E.E. Geduld’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-4,500	Closed	-$231K	–	278
2014 Q2	$231K	Buy	+4,500	New	+$203K	0.14%	168

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

E.E. Geduld's XBI Position: Q3 2014 in Review

E.E. Geduld sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2014, closing a stake of 4,500 shares — an estimated $231K sold.

E.E. Geduld first reported a position in XBI in Q2 2014 and held it in 1 quarter. The position peaked at $231K in Q2 2014. 129 funds tracked by Wall St. Rank hold XBI as of Q3 2014.

E.E. Geduld reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2014 after selling out during the quarter.
E.E. Geduld sold 4,500 State Street SPDR S&P Biotech ETF shares in Q3 2014, an estimated $231K.
E.E. Geduld first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and held it in 1 quarter.
E.E. Geduld's State Street SPDR S&P Biotech ETF position peaked at $231K in Q2 2014.
129 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2014.

Based on E.E. Geduld's 13F filing for Q3 2014, filed 30 Oct 2014.